Pingtan Marine Enterprise (PME) Upgraded at BidaskClub

Pingtan Marine Enterprise (NASDAQ:PME) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday.

Pingtan Marine Enterprise (NASDAQ PME) traded down $0.09 during midday trading on Wednesday, hitting $3.73. 410,200 shares of the stock were exchanged, compared to its average volume of 309,200. The company has a current ratio of 0.60, a quick ratio of 0.55 and a debt-to-equity ratio of 0.14. The firm has a market cap of $286.18, a PE ratio of 8.88 and a beta of 0.96. Pingtan Marine Enterprise has a one year low of $1.68 and a one year high of $5.18.

COPYRIGHT VIOLATION WARNING: “Pingtan Marine Enterprise (PME) Upgraded at BidaskClub” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.com-unik.info/2018/01/10/pingtan-marine-enterprise-pme-upgraded-at-bidaskclub.html.

Pingtan Marine Enterprise Company Profile

Pingtan Marine Enterprise Ltd. is a marine enterprises company. The Company is primarily engaging in ocean fishing through its operating subsidiary, Fujian Provincial Pingtan County Ocean Fishing Group Co, Ltd. (Pingtan Fishing). The Company harvests a range of fish species with its owned and licensed vessels operating within the Indian Exclusive Economic Zone, Indo-Pacific waters, the Arafura Sea of Indonesia, and international waters of Atlantic and Pacific Oceans.

Receive News & Ratings for Pingtan Marine Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pingtan Marine Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit